TrialThe Lancet. Infectious diseases2022

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial.

Emily E Coates et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.